Nav: Home

Greater efforts are needed to address 'financial toxicity' of cancer treatment

July 23, 2018

In addition to facing new concerns about their health, individuals who are diagnosed with cancer often worry about the financial burdens of treatment. A new study indicates that many patients feel that such 'financial toxicity' is not adequately addressed by their doctors and other clinicians. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

There is growing awareness that cancer diagnosis and treatment can create financial difficulties even for patients with health insurance, but it is unclear whether patients today are being helped by their doctors or staff with these challenges. To investigate, Reshma Jagsi, MD, DPhil, of the University of Michigan in Ann Arbor, and her colleagues surveyed patients with early-stage breast cancer and their physicians: 2502 patients, 370 surgeons, 306 medical oncologists, and 169 radiation oncologists.

Half of responding medical oncologists reported that someone in their practice often or always discusses financial burden with patients, as did 15.6 percent of surgeons and 43.2 percent of radiation oncologists. Patients indicated that financial toxicity remains common: 21.5 percent of whites and 22.5 percent of Asians had to cut down spending on food, as did 45.2 percent of blacks and 35.8 percent of Latinas.

The survey also revealed that many patients desired to talk to providers about the financial impact of cancer: 15.2 percent of whites, 31.1 percent of blacks, 30.3 percent of Latinas, and 25.4 percent of Asians. Unmet patient needs for engagement with doctors about financial concerns were common. Of 945 women who worried about finances, 679 (72.8 percent) indicated that doctors and their staff did not help. Of 523 women who desired to talk to providers about the impact of breast cancer on employment or finances, 283 (55.4 percent) reported no relevant discussion.

"We found that even though many doctors reported that they routinely make services available to their patients to help with financial concerns, many patients still reported unmet needs," said Dr. Jagsi.

The investigators noted that although advances in detection and treatment have transformed how breast cancer is perceived and managed, this study reveals an important aspect that cannot be overlooked or addressed as an afterthought. "Efforts must now turn to confront the financial devastation that many patients face, particularly as they progress into survivorship," said Dr. Jagsi. "The first steps for clinical practice and policy are clear: all physicians must assess patients for financial toxicity and learn how to communicate effectively about it. To cure a patient's disease at the cost of financial ruin falls short of the physician's duty to serve--and failure to recognize and mitigate a patient's financial distress is no longer acceptable."
-end-
Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:

Dawn Peters (US) +1 781-388-8408
sciencenewsroom@wiley.com

Follow us on Twitter @WileyNews

Full Citation: "Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer." CANCER; Published Online: July 23, 2018 (DOI: 10.1002/cncr.31532).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.31532

Author Contact: Nicole Fawcett with the University of Michigan Rogel Cancer Center communications office at nfawcett@med.umich.edu or @UMRogelCancer.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.

Follow us on Twitter @JournalCancer

About Wiley

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Wiley

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...